The 4 analysts offering 12-month price forecasts for VolitionRX Ltd have a median target of 4.03, with a high estimate of 4.50 and a low estimate of 2.50. The median estimate represents a +528.02% increase from the last price of 0.64.
The current consensus among 4 polled investment analysts is to Buy stock in VolitionRX Ltd. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.12
Reporting Date Mar 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.